speb/financial-data huggingface dataset:
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Basic EPS: 3.17
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 5.55
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 121400000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 194162000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 194162000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -29000000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 58274000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 58274000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 279290000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 279290000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 56631000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 56631000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1643000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1643000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 39000000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Change In Payable: 10500000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -43800000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 5700000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -56300000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Common Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 819708000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 819708000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 448500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 134400000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Current Assets: 791828000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 791828000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Current Debt: 77426000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 77426000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 77426000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 77426000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 167034000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 167034000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 3000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 3000000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Depreciation: 8200000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 8200000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 8200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2100000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 8200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 2100000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 5394322.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 5405405.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Diluted EPS: 3.17
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 5.55
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 17100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 30000000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — EBIT: 32400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — EBIT: 41900000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — EBITDA: 40600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — EBITDA: 44000000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — End Cash Position: 65100000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 13800000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 146279000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 146279000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -59300000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -1100000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -46900000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 43826000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 917054000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 917054000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Gross Profit: 272500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 74500000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Interest Expense: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 1800000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1800000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Interest Income: 25638000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 25638000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -8400000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 27100000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Inventory: 239418000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 239418000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 897307000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 897307000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -39800000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 60282000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 60282000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 9315000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 9315000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 173000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 173000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 173000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 173000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 20900000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 20900000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 713577000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 713577000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Net Debt: 19325000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 19325000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Net Income: 17100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Net Income: 30000000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 17100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 30000000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 17100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 30000000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 17100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 30000000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 17100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 30000000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 24000000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 17100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 30000000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Net Interest Income: -8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -1800000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Net Investment Properties Purchase And Sale: 0.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -85800000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 22200000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -500000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1800000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Net PPE: 111900000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 111900000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 18900000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 22700000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 819708000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 819708000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 514000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 514000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 34375000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 34375000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 20872000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 20872000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 1045000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1045000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: -4200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -800000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Normalized Income: -14820000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Normalized Income: -3516209.48
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -30300000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Operating Income: -53100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Operating Income: -14500000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Operating Revenue: 721000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 208900000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 5396250.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 5396250.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 77800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 77800000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 7001000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 7001000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 2500000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 2500000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 3688000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 3688000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -17200000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 7446000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 7446000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 500000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 500000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 40700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 11600000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 230500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 66500000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Payable: 10034000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 10034000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Properties: 111900000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 111900000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 15656000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 15656000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 221016000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 221016000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Other Special Charges: -44800000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: -44800000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Payables: 66432000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Payables: 66432000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 3037000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 3037000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 44669000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 44669000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Pretax Income: 24000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 40100000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 0.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -96000000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment Properties: 0.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -29000000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 70416000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 70416000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 448500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 134400000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 8200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2100000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 1986000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 1986000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 8273000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 8273000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Restructuring And Mergern Acquisition: -44800000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 249469000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 249469000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 10200000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 47900000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 34272000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 78098000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Share Issued: 5396250.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 5396250.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Special Income Charges: 44800000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 44800000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 819708000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 819708000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 819708000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 819708000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 12880000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 11283790.52
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Tax Provision: 6900000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 10100000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.29
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 28503000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 28503000.00
ZENITHEXPO.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -3000000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Total Assets: 1008857000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1008857000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 819881000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 819900000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Total Debt: 77599000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 77599000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 819708000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 819708000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Total Expenses: 774100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 223400000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 189149000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 189149000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 217029000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 217029000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 22115000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 22115000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 2816000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 44800000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 44800000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 44800000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 44800000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 56000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 56000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Work In Process: 19035000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 19035000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Working Capital: 624794000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 624794000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Write Off: 1088000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 80300000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 179000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 5405405.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 2.59
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 87400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 1600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 5405405.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.59
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 14000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — EBIT: 21500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — EBITDA: 23100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 91600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 2200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 2200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Net Income: 14000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 14000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 14000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 14000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 14000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 14000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -2200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -2200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 23100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 14000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Operating Income: 11300000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 179000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 10200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 57100000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 19300000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 87400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 5300000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 167700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 89200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 195100000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 44000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 168600000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 96800000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 5384615.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.56
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 54000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 111000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 239300000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 54000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 843200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 5600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 105400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 722800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 30100000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 30100000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 102300000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 4400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 1500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 1500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 5384615.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.56
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — EBIT: 12500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — EBITDA: 14000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 119600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 89700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 1600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1600000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 247500000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 873700000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 96800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 23800000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Net Income: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -1600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1600000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 119600000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 843200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 14000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 8400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Operating Income: 500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 195100000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 5396250.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 67400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 14800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 789200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 33600000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 4200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 12000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 65800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 114000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 128300000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Payables: 44000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 10900000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 105400000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 5396250.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 843200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 843200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 2500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 973900000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 843600000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 30500000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 843200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 194600000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 130700000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 251100000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 28400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 620500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 78900000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 141700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 5483871.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.31
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 66700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 5483871.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.31
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — EBIT: 4800000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 6500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 75000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 1600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Net Income: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -1600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 6500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Operating Income: -3900000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 141700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 8700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 55700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 3200000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 66700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 1500000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 145600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — +Operating Expense: 333600000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 85200000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — +Total Revenue: 646800000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 131000000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 51900000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 51900000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 153200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 153200000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 187400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 187400000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 5400943.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 5454545.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Basic EPS: 4.24
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.22
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 65100000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -10000000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 54000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 54000000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 61000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 61000000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 169100000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 169100000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -18900000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Change In Payable: 3200000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 44700000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 29000000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -4200000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Common Stock: 54000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 54000000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 841100000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 841100000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 0.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 319000000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 59500000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Current Assets: 646200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 646200000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Current Debt: 21200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 21200000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 21200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 21200000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 109600000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 109600000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 5800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 5800000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Depreciation: 7100000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 7100000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 7100000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 2300000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 7100000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 2300000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 5400943.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 5454545.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Diluted EPS: 4.24
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.22
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 22900000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -1200000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — EBIT: 39300000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — EBIT: 500000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — EBITDA: 46400000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — EBITDA: 2800000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — End Cash Position: 60900000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -63300000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 44100000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 3900000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -200000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 87300000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 87300000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Gross Profit: 327800000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 71500000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Interest Expense: 6800000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1400000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 6800000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1400000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -6800000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 28800000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Inventory: 258400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 258400000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 862300000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 862300000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 5000000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 32400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 32400000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 187400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 187400000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 23400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 23400000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Net Income: 22900000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Net Income: -1200000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 22900000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -1200000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 22900000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -1200000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 22900000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -1200000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 22900000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -1200000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 32500000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 22900000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -1200000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Net Interest Income: -6800000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1400000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Net Investment Properties Purchase And Sale: -5000000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -9000000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -56500000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -200000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -6800000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1400000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Net PPE: 87300000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 87300000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -9800000.00
ZENITHEXPO.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -56300000.00
ZENITHEXPO.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 841100000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 841100000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 46400000.00
ZENITHEXPO.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 2800000.00
ZENITHEXPO.NS income_statement (annual, 2026-03-31) — Normalized Income: 22900000.00